Gyre Therapeutics (GYRE) Net Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149,092.00 |
| Dec 31, 2025 | 92,629.00 |
| Sep 30, 2025 | 180,722.00 |
| Jun 30, 2025 | 104,194.00 |
| Mar 31, 2025 | 3,700.00 |
| Mar 31, 2023 | 8.40 Mn |
| Dec 31, 2022 | 177,965.00 |
| Mar 31, 2022 | -30,379.00 |
| Dec 31, 2021 | 444,935.00 |
| Sep 30, 2021 | 327,928.00 |
| Jun 30, 2021 | 267,352.00 |
| Mar 31, 2021 | 176,590.00 |
| Dec 31, 2020 | 503,880.00 |
| Sep 30, 2020 | 151,835.00 |
| Jun 30, 2020 | -53,552.00 |
| Mar 31, 2020 | 98,000.00 |
| Mar 31, 2018 | -8.38 Mn |
| Dec 31, 2017 | 90,715.00 |
| Sep 30, 2017 | -79,579.00 |
| Jun 30, 2017 | -889,713.00 |
| Mar 31, 2017 | -153,682.00 |
| Dec 31, 2016 | -522,994.00 |
| Sep 30, 2016 | -432,930.00 |
| Jun 30, 2016 | -442,306.00 |
| Mar 31, 2016 | -332,769.00 |
| Dec 31, 2015 | -595,985.00 |
| Sep 30, 2015 | -514,170.00 |
| Jun 30, 2015 | -241,487.00 |